BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32924742)

  • 1.
    Si Y; Wang L; Lan J; Li H; Guo T; Chen X; Dong C; Ouyang Z; Chen SQ
    Pharm Biol; 2020 Dec; 58(1):915-924. PubMed ID: 32924742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis.
    Dong YJ; Jiang NH; Zhan LH; Teng X; Fang X; Lin MQ; Xie ZY; Luo R; Li LZ; Li B; Zhang BB; Lv GY; Chen SH
    Biomed Pharmacother; 2021 Nov; 143():112141. PubMed ID: 34509822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive study on the relieving effect of
    Si Y; Wei W; Chen X; Xie X; Guo T; Sasaki Y; Zhang Y; Wang L; Zhang F; Feng S
    Pharm Biol; 2022 Dec; 60(1):131-143. PubMed ID: 34978949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential of Cinnamon Extract (Cinnamomum burmanii) as Anti-insomnia Medication through Hypothalamus Pituitary Adrenal Axis Improvement in Rats.
    Hidayat R; Wulandari P; Reagan M
    Acta Med Acad; 2022 Aug; 51(2):79-84. PubMed ID: 36317999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
    Ginsberg AB; Campeau S; Day HE; Spencer RL
    J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of HPAA in Different Rat Models of Gan Stagnation, Pi Deficiency, Gan Stagnation Pi Defi- ciency and Interventional Effect of Chaishu Sijun Decoction].
    Zhao RH; Liu JN; Li C; Zhang JS; Wang BZ; Yao YC; Xie M; Wang DH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):834-8. PubMed ID: 26380447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of electroacupuncture at different acupoints on hormones and neurotransmitters of hypotha- lamic-pituitary-adrenal axis in rats under simulated weightlessness].
    Zhang H; Zhao G; Wang D; Zhao B; Ji B; Song Y; Zhang P; Liu Y; Li Y
    Zhongguo Zhen Jiu; 2015 Dec; 35(12):1275-9. PubMed ID: 26964178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JIEYUANSHEN DECOCTION EXERTS ANTIDEPRESSANT EFFECTS ON DEPRESSIVE RAT MODEL VIA REGULATING HPA AXIS AND THE LEVEL OF AMINO ACIDS NEUROTRANSMITTER.
    Qiuxia Z; Xinlong M; Yilong Y; Hui Z; Yali W; Xiaoquan Y; Lei W; Jiahui C; Haiyan Z
    Afr J Tradit Complement Altern Med; 2017; 14(2):33-46. PubMed ID: 28573220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
    Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
    Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of kidney yang syndrome by icariin through regulating hypothalamus-pituitary-adrenal axis.
    An R; Li B; You LS; Wang XH
    Chin J Integr Med; 2015 Oct; 21(10):765-71. PubMed ID: 25824551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic exposure to corticosterone modifies aggressive behavior through alterations of the hypothalamic pituitary adrenal axis and the serotonergic system in the chicken.
    Ahmed AA; Ma W; Ni Y; Zhou Q; Zhao R
    Horm Behav; 2014 Feb; 65(2):97-105. PubMed ID: 24333411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal (HPA) axis response to exogenous corticotropin-releasing hormone (CRH) is attenuated in men with chronic insomnia.
    Vgontzas AN; Fernandez-Mendoza J; Lenker KP; Basta M; Bixler EO; Chrousos GP
    J Sleep Res; 2022 Jun; 31(3):e13526. PubMed ID: 34825417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol.
    Hofmann CE; Ellis L; Yu WK; Weinberg J
    Alcohol Clin Exp Res; 2007 Feb; 31(2):345-55. PubMed ID: 17250628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.